Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer
Cancers · 06.11.2023 · 15 (21) · 5304
DOI: 10.3390/cancers15215304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 06.11.2023. Verfasst von Chin-Chia Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colorectal Surgery, Buddhist Tzu Chi Medical Foundation, Dalin Tzu Chi Hospital, Chiayi 622, Taiwan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Buddhist Tzu Chi Medical Foundation.
Abstract (Originalsprache)
The dose–response effect of proton pump inhibitors on colorectal cancer prognosis is still under exploration. This population-based study in Taiwan was designed to examine the effect of proton pump inhibitors on overall death, colorectal cancer-specific death, and recurrence in colorectal cancer patients with different cumulative proton pump inhibitor dose levels. This cohort study was based on the Taiwan Cancer Registry and Taiwan National Health Insurance Research Database from 2005 to 2020. After frequency matching with a 1:1 ratio, a total of 20,889 users with proton pump inhibitors and 20,889 without proton pump inhibitors were analyzed. The cumulative defined daily dose level of proton pump inhibitor was stratified to explore the dose–response relationship. A proton pump inhibitor exposure cumulative defined daily dose > 60 after colorectal cancer diagnosis had higher risk of all-cause death than non-proton pump inhibitor users with adjusted hazard ratios of 1.10 (95% CIs: 1.04–1.18). For recurrence, a proton pump inhibitor exposure cumulative defined daily dose > 60 had reduced recurrence risk with an adjusted hazard ratio of 0.84 (95% CIs: 0.76–0.93). This study demonstrated that the long-term use of proton pump inhibitors in patients with colorectal cancer was associated with an increased risk of death that related to the proton pump inhibitor exposure cumulative defined daily dose > 60 and had different dose–response effect in various dose level.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Colorectal Surgery, Buddhist Tzu Chi Medical Foundation, Dalin Tzu Chi Hospital, Chiayi 622, Taiwan.
- School of Post-Baccalaureate Chinese Medicine, Tzu Chi University, Hualien 970374, Taiwan.
- Division of Colon and Rectal Surgery, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi 600566, Taiwan.
- Department of Radiation Oncology, Buddhist Tzu Chi Medical Foundation, Dalin Tzu Chi Hospital, Chiayi 622, Taiwan.
- Department of General Surgery, Buddhist Tzu Chi Medical Foundation, Hualien Tzu Chi Hospital, Hualien 970, Taiwan.
- School of Medicine, Tzu Chi University, Hualien 970, Taiwan.
ORCID-Profile: Wen-Yen Chiou, Jui-Hsiu Tsai
Förderung
- Buddhist Tzu Chi Medical Foundation
Zitieren
APA
Wu, C. C., Fang, C. Y., Yu, B. H., Chang, C. M., Hsu, T. W., Hung, C. L., Hung, S. K., Chiou, W. Y., & Tsai, J. H. (2023). Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer. Cancers, 15(21), 5304. https://doi.org/10.3390/cancers15215304
Vancouver
Wu CC, Fang CY, Yu BH, Chang CM, Hsu TW, Hung CL, et al. Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer. Cancers. 2023;15(21):5304. doi:10.3390/cancers15215304
BibTeX
@article{Wu2023,
author = {Wu, Chin-Chia and Fang, Chuan-Yin and Yu, Ben-Hui and Chang, Chun-Ming and Hsu, Ta-Wen and Hung, Chung-Lin and Hung, Shih-Kai and Chiou, Wen-Yen and Tsai, Jui-Hsiu},
title = {Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer},
journal = {Cancers},
year = {2023},
volume = {15},
number = {21},
pages = {5304},
doi = {10.3390/cancers15215304}
}
EUVIMED